Stenting improves quality of life in the management of oesophageal cancer patients
Intended for healthcare professionals
Clinical Previous    

Stenting improves quality of life in the management of oesophageal cancer patients

Karen Bailey Cancer genetics counsellor, Institute of Medical Genetics, Cancer Genetics Service, University Hospital of Wales, Cardiff
Susan Morgan Palliative care clinical nurse specialist, Palliative care department, University Hospital of Wales, Cardiff

Oesophageal cancer has a poor prognosis with an overall survival rate of approximately 10 per cent. The most debilitating and distressing symptom associated with this disease is dysphagia and, given the poor prognosis, maintaining patients’ quality of life is of prime importance. This article focuses on the use of self-expanding metal stents which are often used to relieve the experience of dysphagia for these patients. It describes an audit of a care pathway in the Cardiff and Vale NHS Trust which demonstrated an improvement in the coordination of care.

Cancer Nursing Practice. 7, 3, 40-45. doi: 10.7748/cnp2008.04.7.3.40.c6462

Want to read more?

RCNi-Plus
Already have access? Log in

or

3-month trial offer for £5.25/month

Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
  • Unlimited access to all 10 RCNi Journals
  • RCNi Learning featuring over 175 modules to easily earn CPD time
  • NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
  • Personalised newsletters tailored to your interests
  • A customisable dashboard with over 200 topics
Subscribe

Alternatively, you can purchase access to this article for the next seven days. Buy now


Are you a student? Our student subscription has content especially for you.
Find out more